Latest Breaking News On - Weiguang yang - Page 1 : comparemela.com

Zhongchao Inc (ZCMD) Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications

Zhongchao Inc (ZCMD) Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Weiguang yangResearch groupJournal of peking union medical college hospitalShanghai zhongxin medical technology co ltdZhongchao incSystemic lupus erythematosusPossible solutionsCurrent situationMedical journalPeking union medical college hospital

Zhongchao : NASDAQ Notification Regarding Minimum Bid Price Deficiency - Form 6-K -January 03, 2024 at 07:02 am EST

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER.

United statesWeiguang yangNasdaq stock marketNanxi creative centerCompany classZhongchao incPrincipal executive officeCreative centerRegarding minimum bid priceNasdaq ruleBid priceNasdaq listing ruleMinimum bid priceMinimum bid price requirementCompliance periodNasdaq capital market

TradeUP Acquisition Corp and Estrella Biopharma, Inc Announce Completion of Business Combination

TradeUP Acquisition Corp and Estrella Biopharma, Inc Announce Completion of Business Combination
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Weiguang yangCheng liuEstrella biopharma incUs tiger securities incTradeup acquisition corpUs securities exchangeWinston strawnEstrella immunopharma incPrnewswire estrella immunopharma incRobinson coleBegin tradingTicker symbolsEstrella biopharmaEstrella immunopharmaEstrella founderCytokine release syndrome

Zhongchao Inc Introduces PRO-Based Disease Management Model for Lung Cancer Patients

SHANGHAI, Sept. 25, 2023 /PRNewswire/ Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced the introduction of its Patient-Reported Outcome (PRO) -based symptom management model. This model is geared toward aiding the recovery of lung cancer patients and enhancing their life quality..

Cayman islandsPei xuWeiguang yangSherry zhengZhongchao incPrnewswire zhongchao incSunshine health forumsZhongchao medical technology shanghaiWeitian groupPatient reported outcomeSymptom monitoringResponse systemChief executive officerZhongchao medical technologyZhixun internet hospitalXinjiang medical

Zhongchao Inc Introduces PRO-Based Disease Management Model for Lung Cancer Patients

Zhongchao Inc Introduces PRO-Based Disease Management Model for Lung Cancer Patients
thailand-business-news.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thailand-business-news.com Daily Mail and Mail on Sunday newspapers.

Cayman islandsWeiguang yangSherry zhengPei xuSunshine health forumsZhongchao medical technology shanghaiWeitian groupZhongchao incPatient reported outcomeSymptom monitoringResponse systemChief executive officerZhongchao medical technologyZhixun internet hospitalXinjiang medicalPrivate securities litigation reform act